Literature DB >> 31503351

The first European guidelines on phenylketonuria: Usefulness and implications for BH4 responsiveness testing.

Roeland A F Evers1, Annemiek M J van Wegberg1, Karen Anjema1, Charlotte M A Lubout1, Esther van Dam1, Danique van Vliet1, Nenad Blau2, Francjan J van Spronsen1.   

Abstract

OBJECTIVE: This study aimed to investigate and improve the usefulness of the 48-hour BH4 loading test and to assess genotype for BH4 responsiveness prediction, using the new definition of BH4 responsiveness from the European guidelines, as well as an amended definition.
METHOD: Applying the definition of the European guidelines (≥100% increase in natural protein tolerance) and an amended definition (≥100% increase in natural protein tolerance or tolerating a safe natural protein intake) to a previous dataset, we first assessed the positive predictive value (PPV) of the 48-hour BH4 loading test using a cutoff value of 30%. Then, we tried to improve this PPV by using different cutoff values and separate time points. Last, using the BIOPKU database, we compared predicted BH4 responsiveness (according to genotype) and genotypic phenotype values (GPVs) in BH4 -responsive and BH4 -unresponsive patients.
RESULTS: The PPV of the 48-hour loading test was 50.0% using the definition of the European guidelines, and 69.4% when applying the amended definition of BH4 responsiveness. Higher cutoff values led to a higher PPV, but resulted in an increase in false-negative tests. Parameters for genotype overlapped between BH4 -responsive and BH4 -unresponsive patients, although BH4 responsiveness was not observed in patients with a GPV below 2.4.
CONCLUSION: The 48-hour BH4 loading test is not as useful as previously considered and cannot be improved easily, whereas genotype seems mainly helpful in excluding BH4 responsiveness. Overall, the definition of BH4 responsiveness and BH4 responsiveness testing require further attention.
© 2019 SSIEM.

Entities:  

Keywords:  European guidelines; definition; loading test; phenylketonuria; responsiveness; tetrahydrobiopterin

Mesh:

Substances:

Year:  2019        PMID: 31503351     DOI: 10.1002/jimd.12173

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  7 in total

1.  The Genetic Landscape and Epidemiology of Phenylketonuria.

Authors:  Alicia Hillert; Yair Anikster; Amaya Belanger-Quintana; Alberto Burlina; Barbara K Burton; Carla Carducci; Ana E Chiesa; John Christodoulou; Maja Đorđević; Lourdes R Desviat; Aviva Eliyahu; Roeland A F Evers; Lena Fajkusova; François Feillet; Pedro E Bonfim-Freitas; Maria Giżewska; Polina Gundorova; Daniela Karall; Katya Kneller; Sergey I Kutsev; Vincenzo Leuzzi; Harvey L Levy; Uta Lichter-Konecki; Ania C Muntau; Fares Namour; Mariusz Oltarzewski; Andrea Paras; Belen Perez; Emil Polak; Alexander V Polyakov; Francesco Porta; Marianne Rohrbach; Sabine Scholl-Bürgi; Norma Spécola; Maja Stojiljković; Nan Shen; Luiz C Santana-da Silva; Anastasia Skouma; Francjan van Spronsen; Vera Stoppioni; Beat Thöny; Friedrich K Trefz; Jerry Vockley; Youngguo Yu; Johannes Zschocke; Georg F Hoffmann; Sven F Garbade; Nenad Blau
Journal:  Am J Hum Genet       Date:  2020-07-14       Impact factor: 11.025

Review 2.  Phenylketonuria.

Authors:  Francjan J van Spronsen; Nenad Blau; Cary Harding; Alberto Burlina; Nicola Longo; Annet M Bosch
Journal:  Nat Rev Dis Primers       Date:  2021-05-20       Impact factor: 52.329

3.  Ligustilide Prevents Radiation Enteritis by Targeting Gch1/BH4/eNOS to Improve Intestinal Ischemia.

Authors:  Tao Yan; Shun Guo; Tian Zhang; Zhimin Zhang; An Liu; Song Zhang; Yuan Xu; Yuhong Qi; Weihe Zhao; Qinhui Wang; Lei Shi; Linna Liu
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 4.  PKU dietary handbook to accompany PKU guidelines.

Authors:  A MacDonald; A M J van Wegberg; K Ahring; S Beblo; A Bélanger-Quintana; A Burlina; J Campistol; T Coşkun; F Feillet; M Giżewska; S C Huijbregts; V Leuzzi; F Maillot; A C Muntau; J C Rocha; C Romani; F Trefz; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2020-06-30       Impact factor: 4.123

5.  An Updated PAH Mutational Spectrum of Phenylketonuria in Mexican Patients Attending a Single Center: Biochemical, Clinical-Genotyping Correlations.

Authors:  Marcela Vela-Amieva; Miguel Angel Alcántara-Ortigoza; Isabel Ibarra-González; Ariadna González-Del Angel; Liliana Fernández-Hernández; Sara Guillén-López; Lizbeth López-Mejía; Rosa Itzel Carrillo-Nieto; Leticia Belmont-Martínez; Cynthia Fernández-Lainez
Journal:  Genes (Basel)       Date:  2021-10-23       Impact factor: 4.096

6.  Italian national consensus statement on management and pharmacological treatment of phenylketonuria.

Authors:  Alberto Burlina; Giacomo Biasucci; Maria Teresa Carbone; Chiara Cazzorla; Sabrina Paci; Francesca Pochiero; Marco Spada; Albina Tummolo; Juri Zuvadelli; Vincenzo Leuzzi
Journal:  Orphanet J Rare Dis       Date:  2021-11-16       Impact factor: 4.123

7.  Bone Status in Patients with Phenylketonuria: A Systematic Review.

Authors:  María José de Castro; Carmela de Lamas; Paula Sánchez-Pintos; Domingo González-Lamuño; María Luz Couce
Journal:  Nutrients       Date:  2020-07-20       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.